MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}.
Louafi
Fethi
F
JunkRNA Laboratory, Division of Infection, Inflammation and Immunity, University of Southampton School of Medicine, Southampton General Hospital, Southampton SO16 6YD, United Kingdom.
Martinez-Nunez
Rocio T
RT
Sanchez-Elsner
Tilman
T
D001665:Binding Sites; D002460:Cell Line; D005355:Fibrosis / Q000378:metabolism; D005786:Gene Expression Regulation; D006367:HeLa Cells; D006801:Humans; D008264:Macrophages / Q000378:metabolism*; D035683:MicroRNAs / Q000378:metabolism*; D022423:Myeloid Cells; D009389:Neovascularization, Pathologic / Q000378:metabolism; D011485:Protein Binding; D051899:Smad2 Protein / Q000378:metabolism*; D016212:Transforming Growth Factor beta / Q000378:metabolism*; D019076:Transgenes
C524942:MIRN155 microRNA, human; D035683:MicroRNAs; C497782:SMAD2 protein, human; D051899:Smad2 Protein; D016212:Transforming Growth Factor beta